This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Cimarex Announces Tender Offer And Consent Solicitation

DENVER, March 22, 2012 /PRNewswire/ -- Cimarex Energy Co. (NYSE: XEC) announced today that it has commenced a cash tender offer (the "Tender Offer") to purchase any and all of its outstanding $350 million aggregate principal amount of 7 1/8% Senior Notes due 2017 (the "Notes")  (CUSIP 171798AA9).

In connection with the Tender Offer, Cimarex is soliciting consents (the "Consent Solicitation") from the holders of the Notes for certain proposed amendments that would eliminate or modify certain covenants and events of default and other provisions contained in the indenture governing the Notes (the "Indenture"). Holders who tender their Notes will be deemed to consent to the proposed amendments and holders may not deliver consents to the proposed amendments without tendering their Notes in the Tender Offer. The Tender Offer and Consent Solicitation are being made pursuant to the Offer to Purchase and Consent Solicitation Statement, dated March 22, 2012 (the "Offer to Purchase"), and a related Consent and Letter of Transmittal, which more fully set forth the terms and conditions of the Tender Offer and Consent Solicitation.

The Tender Offer will expire at midnight, Eastern Time, on April 18, 2012, unless the Tender Offer is extended or earlier terminated (such date and time, as the same may be extended, the "Expiration Time").  Under the terms of the Tender Offer, holders of the Notes who validly tender and do not validly withdraw their Notes prior to 5:00 p.m., Eastern Time, on April 4, 2012 (as such time and date may be extended, the "Consent Expiration") and whose notes are accepted for purchase, will receive the "Total Consideration," which is equal to (i) $1,035.63 per $1,000.00 in principal amount of Notes validly tendered (the "Tender Offer Consideration") plus (ii) a consent payment of $3.75 per $1,000.00 in principal amount of the Notes validly tendered (the "Consent Payment").  Holders of Notes who validly tender their Notes after the Consent Expiration but on or prior to the Expiration Time, and whose notes are accepted for purchase, will receive only the Tender Offer Consideration.  All holders whose Notes are accepted in the Tender Offer will also receive accrued and unpaid interest up to, but excluding, the applicable settlement date.

The Tender Offer contemplates an early settlement option, so that holders whose Notes are validly tendered prior to the Consent Expiration and accepted for purchase could receive payment as early as April 5, 2012. Tendered Notes may be withdrawn and consents may be revoked before 5:00 p.m., Eastern Time, on April 4, 2012, unless extended.

Any extension, termination or amendment of the Tender Offer will be followed as promptly as practicable by a public announcement thereof.  The Tender Offer is subject to the satisfaction of certain conditions including: (1) the execution of a supplemental indenture implementing the proposed amendments to the Indenture upon receipt of consents thereto from holders of a majority in principal amount of the outstanding Notes governed by such Indenture, excluding any such Notes owned by the Company or its affiliates, (2)  completion of a satisfactory financing transaction yielding sufficient net proceeds to fund the purchase of the Notes in the Tender Offer and the payment for consents in the Consent Solicitation and (3) certain other customary conditions.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs